PolarityTE Separation, Transition and Release of Claims AgreementSeparation, Transition and Release of Claims Agreement • April 1st, 2020 • Polarityte, Inc. • Biological products, (no disgnostic substances) • Utah
THIS SEPARATION, TRANSITION AND RELEASE OF CLAIMS AGREEMENT (the “Agreement”) is entered into as of the 31st day of March 2020 (the “Transition Date”) by and between Paul E. Mann (the “Employee”); and PolarityTE, Inc., a Delaware corporation, and PolarityTE MD, Inc., a Nevada corporation, and subsidiary of PolarityTE, Inc. (collectively the “Company”). Employee and the Company are collectively referred to as the “Parties”.
AMENDMENT TO SEPARATION, TRANSITION, AND RELEASE OF CLAIMS AGREEMENTSeparation, Transition, and Release of Claims Agreement • March 4th, 2015 • Cerulean Pharma Inc. • Pharmaceutical preparations • Massachusetts
This Amendment (“Amendment”) is made by and between Oliver S. Fetzer, Ph.D (“Fetzer”) and Cerulean Pharma Inc. (“Cerulean” or the “Company”) (together, the “Parties”). Any capitalized term used but not otherwise defined herein shall have the meaning assigned to it in the Agreement (as defined below).
SEPARATION, TRANSITION, AND RELEASE OF CLAIMS AGREEMENTSeparation, Transition, and Release of Claims Agreement • October 30th, 2014 • Cerulean Pharma Inc. • Pharmaceutical preparations • Massachusetts
This Separation, Transition and Release of Claims Agreement (the “Agreement”) is made by and between Oliver S. Fetzer, Ph.D (the “Employee”) and Cerulean Pharma Inc. (“Cerulean” or the “Company”) (together, the “Parties”).
